Adam Savitz - 11 Feb 2026 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Erin R. McQuade, Attorney-in-Fact
Issuer symbol
ANRO
Transactions as of
11 Feb 2026
Net transactions value
$0
Form type
4
Filing time
13 Feb 2026, 17:19:32 UTC
Previous filing
08 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Savitz Adam CHIEF MEDICAL OFFICER C/O ALTO NEUROSCIENCE, INC., 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW /s/ Erin R. McQuade, Attorney-in-Fact 13 Feb 2026 0002008707

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANRO Employee Stock Option (Right to Buy) Award $0 +124,000 $0.000000 124,000 11 Feb 2026 Common Stock 124,000 $16.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option shall vest on February 11, 2027, and one forty-eighth (1/48th) of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.